SOAT1 and systemic lupus erythematosus: Continued research into novel therapies, including those targeting less-studied cytokines such as IL-6 and IL-15 and the JAK/STAT pathway, is therefore essential for improving patient outcomes and may contribute to the development of personalized therapeutic strategies in SLE in the future.